» Articles » PMID: 33498655

Escape from X Chromosome Inactivation and the Female Predominance in Autoimmune Diseases

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jan 27
PMID 33498655
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Women represent 80% of people affected by autoimmune diseases. Although, many studies have demonstrated a role for sex hormone receptor signaling, particularly estrogens, in the direct regulation of innate and adaptive components of the immune system, recent data suggest that female sex hormones are not the only cause of the female predisposition to autoimmunity. Besides sex steroid hormones, growing evidence points towards the role of X-linked genetic factors. In female mammals, one of the two X chromosomes is randomly inactivated during embryonic development, resulting in a cellular mosaicism, where about one-half of the cells in a given tissue express either the maternal X chromosome or the paternal one. X chromosome inactivation (XCI) is however not complete and 15 to 23% of genes from the inactive X chromosome (Xi) escape XCI, thereby contributing to the emergence of a female-specific heterogeneous population of cells with bi-allelic expression of some X-linked genes. Although the direct contribution of this genetic mechanism in the female susceptibility to autoimmunity still remains to be established, the cellular mosaicism resulting from XCI escape is likely to create a unique functional plasticity within female immune cells. Here, we review recent findings identifying key immune related genes that escape XCI and the relationship between gene dosage imbalance and functional responsiveness in female cells.

Citing Articles

X-chromosome-linked miR-542-5p as a key regulator of sex disparity in rats with adjuvant-induced arthritis by promoting Th17 differentiation.

Yang J, Li Z, Wang L, Huang B, Ng J, Xu X Biomark Res. 2025; 13(1):36.

PMID: 40025567 PMC: 11872315. DOI: 10.1186/s40364-025-00741-x.


Salt sensitivity of blood pressure: mechanisms and sex-specific differences.

Masenga S, Wandira N, Cattivelli-Murdoch G, Saleem M, Beasley H, Hinton Jr A Nat Rev Cardiol. 2025; .

PMID: 39984695 DOI: 10.1038/s41569-025-01135-0.


Synergistic Effects of Extra X Chromosome on Development of Systemic Lupus Erythematosus and Sjögren Disease in Klinefelter and Triple X Syndrome: A Retrospective Cohort Study.

Palmer A, Tan I ACR Open Rheumatol. 2025; 7(1):e11778.

PMID: 39846238 PMC: 11755114. DOI: 10.1002/acr2.11778.


Sex-specific Associations of Gene Expression with Alzheimer's Disease Neuropathology and Ante-mortem Cognitive Performance.

Seto M, Clifton M, Gomez M, Coughlan G, Gifford K, Jefferson A bioRxiv. 2025; .

PMID: 39803447 PMC: 11722314. DOI: 10.1101/2025.01.02.631098.


Evaluation of Treatment Outcomes Among Individuals on Highly Active Antiretroviral Therapy in KwaZulu-Natal, South Africa.

Muzumbukilwa T, Manimani R, Mushebenge A, Vagiri R, Nlooto M AIDS Res Treat. 2024; 2024:8834740.

PMID: 39691492 PMC: 11651757. DOI: 10.1155/arat/8834740.


References
1.
Smith-Bouvier D, Divekar A, Sasidhar M, Du S, Tiwari-Woodruff S, King J . A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med. 2008; 205(5):1099-108. PMC: 2373842. DOI: 10.1084/jem.20070850. View

2.
Pinheiro I, Dejager L, Libert C . X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females. Bioessays. 2011; 33(11):791-802. DOI: 10.1002/bies.201100047. View

3.
Zuk M . The sicker sex. PLoS Pathog. 2009; 5(1):e1000267. PMC: 2628977. DOI: 10.1371/journal.ppat.1000267. View

4.
Azar P, Mejia J, Cenac C, Shaiykova A, Youness A, Laffont S . TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in women. JCI Insight. 2020; 5(12). PMC: 7406249. DOI: 10.1172/jci.insight.136047. View

5.
Gonzalez-Quintial R, Nguyen A, Kono D, Oldstone M, Theofilopoulos A, Baccala R . Lupus acceleration by a MAVS-activating RNA virus requires endosomal TLR signaling and host genetic predisposition. PLoS One. 2018; 13(9):e0203118. PMC: 6130858. DOI: 10.1371/journal.pone.0203118. View